• 10328 Citations
  • 48 Scopus h-Index
1976 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Evanthia Galanis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Measles virus Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Glioma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Oncolytic Virotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2021

Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer

Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Galanis, E., Knutson, K. L., Hartmann, L. C., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E., Keeney, G., Shridhar, V., Cliby, W. A., Goode, E. L., Peng, K., Hartmann, L. C. & Lingle, W. L.

National Institutes of Health

10/1/088/31/20

Project: Research project

Ovarian Neoplasms
alvocidib
Registries
Research
Translational Medical Research
Breast Neoplasms
Research Personnel
Research
Biostatistics
Translational Medical Research
Measles virus
Measles
Glioma
Glioblastoma
Therapeutics
Measles
Ovarian Neoplasms
Measles virus
Cyclophosphamide
Neoplasms

Research Output 1996 2019

1 Citation (Scopus)

Advances in multidisciplinary therapy for meningiomas

International Consortium on Meningiomas, Jan 14 2019, In : Neuro-Oncology. 21, 1, p. i18-i31

Research output: Contribution to journalArticle

Meningioma
trabectedin
Therapeutics
Radiotherapy
Focal Adhesion Protein-Tyrosine Kinases

A key anti-viral protein, RSAD2/VIPERIN, restricts the release of Measles virus in infected cells

Kurokawa, C., Iankov, I. D. & Galanis, E., Apr 2 2019, In : Virus Research. 263, p. 145-150 6 p.

Research output: Contribution to journalArticle

Measles virus
Protein S
Viral Proteins
Methionine
Interferons

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

Galanis, E., Anderson, S. K., Twohy, E. L., Carrero, X. W., Dixon, J. G., Tran, D. D., Jeyapalan, S. A., Anderson, D. M., Kaufmann, T. J., Feathers, R. W., Giannini, C., Buckner, J. C., Anastasiadis, P. Z. & Schiff, D., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Glioblastoma
Placebos
Neoplasms
Therapeutics
National Cancer Institute (U.S.)
Open Access
Oligodendroglioma
Astrocytoma
Names
Publications
Neoplasms

Interferon signaling predicts response to oncolytic virotherapy

Kurokawa, C. & Galanis, E., Feb 1 2019, In : Oncotarget. 10, 16, p. 1544-1545 2 p.

Research output: Contribution to journalEditorial

Oncolytic Virotherapy
Permissiveness
Measles
Interferons